CI Investments Inc. Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

CI Investments Inc. trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 83.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,746 shares of the medical equipment provider’s stock after selling 66,522 shares during the period. CI Investments Inc.’s holdings in Intuitive Surgical were worth $3,845,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Qube Research & Technologies Ltd lifted its position in Intuitive Surgical by 444.2% during the 4th quarter. Qube Research & Technologies Ltd now owns 78,589 shares of the medical equipment provider’s stock valued at $28,237,000 after acquiring an additional 64,147 shares during the period. abrdn plc raised its holdings in Intuitive Surgical by 185.5% in the fourth quarter. abrdn plc now owns 115,591 shares of the medical equipment provider’s stock worth $41,532,000 after buying an additional 75,107 shares during the last quarter. Baird Financial Group Inc. raised its holdings in Intuitive Surgical by 212.5% in the fourth quarter. Baird Financial Group Inc. now owns 20,608 shares of the medical equipment provider’s stock worth $7,405,000 after buying an additional 14,013 shares during the last quarter. 55I LLC grew its stake in shares of Intuitive Surgical by 246.0% in the fourth quarter. 55I LLC now owns 782 shares of the medical equipment provider’s stock worth $281,000 after acquiring an additional 556 shares during the period. Finally, NorthCrest Asset Manangement LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $306,000. 82.44% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently commented on ISRG shares. Piper Sandler lifted their price target on shares of Intuitive Surgical from $255.00 to $260.00 and gave the stock an “overweight” rating in a research note on Thursday, August 18th. Wells Fargo & Company reduced their price target on shares of Intuitive Surgical to $265.00 in a research note on Friday, July 22nd. BTIG Research cut their target price on shares of Intuitive Surgical from $355.00 to $247.00 and set a “buy” rating for the company in a research report on Monday, July 18th. TheStreet lowered shares of Intuitive Surgical from a “b-” rating to a “c+” rating in a research report on Thursday, May 19th. Finally, Truist Financial cut their target price on shares of Intuitive Surgical from $270.00 to $255.00 and set a “buy” rating for the company in a research report on Friday, July 22nd. Six equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $268.67.

Intuitive Surgical Stock Performance

ISRG stock opened at $203.67 on Friday. Intuitive Surgical, Inc. has a one year low of $186.83 and a one year high of $369.69. The company’s fifty day moving average price is $218.76 and its 200-day moving average price is $242.85. The company has a market capitalization of $72.73 billion, a PE ratio of 51.82, a price-to-earnings-growth ratio of 5.82 and a beta of 1.29.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last released its earnings results on Thursday, July 21st. The medical equipment provider reported $1.14 EPS for the quarter, topping the consensus estimate of $1.01 by $0.13. Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. During the same period in the prior year, the firm earned $1.42 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 3.76 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 6,375 shares of the business’s stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the transaction, the director now owns 11,224 shares of the company’s stock, valued at $2,671,760.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, Director Amal M. Johnson sold 6,375 shares of the company’s stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the sale, the director now owns 11,224 shares of the company’s stock, valued at $2,671,760.96. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Gary S. Guthart sold 79,412 shares of the company’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the sale, the chief executive officer now directly owns 54,607 shares in the company, valued at approximately $11,811,494.10. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 94,787 shares of company stock valued at $20,719,321. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.